News from veracyte, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 28, 2016, 07:30 ET

Veracyte Receives Regulatory Authorization to Offer Percepta™ Bronchial Genomic Classifier for Patients in New York State

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has...

Jan 27, 2016, 08:00 ET

Veracyte to Participate in Two Upcoming Investor Conferences

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Leerink...

Jan 22, 2016, 07:30 ET

Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma® Gene Expression Classifier

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data demonstrating...

Jan 07, 2016, 16:10 ET

Veracyte Announces Expansion to New South San Francisco Facility

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that the company is...

Dec 21, 2015, 08:00 ET

Veracyte to Present at the 34th Annual J.P. Morgan Healthcare Conference

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the 34th Annual...

Dec 14, 2015, 16:05 ET

Veracyte Announces Positive Coverage Policy for the Afirma® Gene Expression Classifier from Health Care Service Corporation (HCSC)

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Health Care...

Nov 18, 2015, 08:00 ET

Veracyte to Present at Piper Jaffray 27th Annual Healthcare Conference

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will participate in a fireside...

Nov 17, 2015, 19:00 ET

Veracyte Applauds CMS Decision to Use "Gapfill" Pricing for the Afirma® Gene Expression Classifier

Veracyte, Inc. (NASDAQ: VCYT) issued a statement in response to the Centers for Medicare and Medicaid Services' (CMS) decision to use a "gapfill"...

Nov 16, 2015, 16:05 ET

Veracyte Names Tina S. Nova, Ph.D. to Its Board of Directors

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that Tina S. Nova,...

Nov 12, 2015, 17:15 ET

Veracyte Announces New Data Supporting Advancement of Its IPF Program Presented Today at PFF Summit 2015

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that studies...

Nov 05, 2015, 16:05 ET

Veracyte Announces Third Quarter 2015 Financial Results

 Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the third quarter ended September 30, 2015 and provided an update on...

Nov 04, 2015, 07:30 ET

Veracyte Announces Data to be Presented at PFF Summit 2015 Highlighting IPF Diagnostic Challenges and Potential of New Genomic-Based Testing Approaches

Veracyte, Inc. (NASDAQ: VCYT) announced that company and external researchers will present four abstracts at the PFF Summit 2015: From Bench to...

Oct 29, 2015, 11:24 ET

Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2015 Financial Results on Thursday, November 5, 2015

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced today that its third...

Oct 21, 2015, 09:20 ET

Veracyte Presents New Data on Gene Variants and Fusions In Thyroid Cancer Diagnosis

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced findings from a new...

Oct 21, 2015, 09:00 ET

Two New Studies Demonstrate the Long-Term Clinical Utility of Veracyte's Afirma® Gene Expression Classifier in Safely Reducing Unnecessary Thyroid Surgeries

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from two new studies...

Oct 20, 2015, 07:30 ET

Veracyte Announces Data Supporting Use of the Percepta™ Bronchial Genomic Classifier to Be Presented at CHEST 2015

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data assessing the...

Oct 19, 2015, 16:44 ET

Veracyte CEO Bonnie Anderson Urges CMS to Reverse Its Proposed 2016 Pricing Methodology for Advanced Molecular Diagnostic Tests

Veracyte, Inc. (NASDAQ: VCYT) announced that Bonnie Anderson, president and chief executive officer, today urged the Centers for Medicare and...

Oct 16, 2015, 07:30 ET

Veracyte Announces Data from Multiple Afirma® Gene Expression Classifier Studies to Be Presented at the 15th International Thyroid Congress

Veracyte, Inc. (NASDAQ: VCYT) today announced that company scientists and external researchers will present multiple oral and poster presentations...

Oct 15, 2015, 16:05 ET

New American Thyroid Association Guidelines Include Recommendation for Veracyte's Afirma® Gene Expression Classifier to Rule Out Cancer in Indeterminate Thyroid Nodules

Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that new guidelines from...

Sep 28, 2015, 01:00 ET

Veracyte Statement on CMS's Preliminary 2016 Clinical Laboratory Fee Schedule and Proposed PAMA Rule

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today issued the following...